✦ LIBER ✦

Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone

✍ Scribed by Brendan Johnson; Laurel Adams; Emily Lu; Ke Zhang; Peter Lebowitz; Christian Lates; Robert Blum

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 189 KB
Volume: 17
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-008-0571-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of casopitant, a novel NK-1 antag

Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron

✍ Laurel M. Adams; Brendan Johnson; Ke Zhang; Lin Yue; Lyndon C. Kirby; Peter Lebo 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 161 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

✍ Teddy Kosoglou; Larisa Reyderman; Renger G. Tiessen; André A. van Vliet; Robert 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 504 KB

Pharmacokinetics of ezlopitant, a novel

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

✍ Anne E. Reed-Hagen; Megumi Tsuchiya; Kaoru Shimada; Jo-Ann Wentland; R. Scott Ob 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

Syntheses of 3-phenyl substituted indoli

Syntheses of 3-phenyl substituted indolizidin-2-ones and a pyrrolizidin-2-one on the route to constrained potential NK1 receptor antagonists

✍ Franca M. Cordero; Alberto Brandi; Simone Cristilli; Francesco De Sarlo; Giovann 📂 Article 📅 1994 🏛 Elsevier Science 🌐 French ⚖ 981 KB

Combined data from two phase III trials

Combined data from two phase III trials of the NK1antagonist aprepitant plus a 5HT3antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response

✍ P. J. Hesketh; S. M. Grunberg; J. Herrstedt; R. de Wit; R. J. Gralla; A. D. Cari 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 124 KB